Abstract:Abstract Background Despite increasing demand for breast capsular surgery to treat various benign and malignant implant-related pathologies, high-quality evidence elucidating complication profiles of capsulectomy and capsulotomy is lacking. Objectives We provide the largest-scale analysis of associated outcomes and complications using the Tracking Operations and Outcomes for Plastic Surgeons (TOPS) database, and investigate clinical scenarios that may subject patients to increased risks for complications, most notably, extent of capsular surgery (complete vs partial), and index indication of implantation (aesthetic vs reconstructive). Methods An analysis of the TOPS database from 2008-2019 was performed. CPT codes were used to identify complete capsulectomy and partial capsulectomy/capsulotomy cases. Breast implant exchange procedures constituted procedural controls. Results In total, 7,486 patients (10,703 breasts) undergoing capsulectomy or capsulotomy were assessed. Relative to controls, capsulectomy (4.40% vs 5.79%; p = 0.0154), but not capsulotomy (4.40% vs 4.50%; p = 0.8876), demonstrated higher overall complication rates. Both capsulectomies (0.83% vs 0.23%; p < 0.0001) and capsulotomies (0.56% vs 0.23%; p = 0.0307) also had greater rates of seroma relative to controls. Subgroup analyses demonstrated that reconstructive patients, relative to aesthetic patients, experienced greater overall complications (6.76% vs 4.34%; p < 0.0001), and increased risks for seroma (1.06% vs 0.47%; p = 0.0016), dehiscence (0.46% vs 0.14%; p = 0.0059), surgical site infections (1.03% vs 0.23%; p < 0.0001), and implant loss (0.52% vs 0.23%; p = 0.0401). A detailed synthesis of 30-day outcomes, including all patient- and breast-specific complications, for both capsulectomy and capsulotomy, stratified according to all potential confounders, is presented herein. Conclusions Surgeries on the breast capsule are overall safe, though complete capsulectomies and reconstructive patients were associated with significantly increased operative risks. Present findings will enhance patient selection, counselling, and informed consent.

Medical Specialist Care Utilization Prior to the Explantation of Cosmetic Silicone Breast Implants: A Nationwide Retrospective Data Linkage Study

Breast implant illness: A United Kingdom patient-centred approach

Breast Implant Illness as a Clinical Entity: A Systematic Review of the Literature

The Problem of Diagnostic Criteria of Breast Implant Illness in Women After Breast Reconstruction: Review and Discussion of a Case

Symptom Improvement After Explantation With No Capsulectomy for Systemic Symptoms Associated With Breast Implants

Major Clinical Adverse Events of Breast Implant in the Manufacturer and User Facility Device Experience Database

Breast implant reverse surgery: A step-by-step approach

Examining the Outcomes and Underlying Mechanisms of Squamous Cell Carcinoma in Breast Implant Patients—A Systematic Review

Comprehensive Systematic Review of Breast Implant Illness: Symptoms, Management, and Long-Term Outcomes

Long-term Implications of Cosmetic Breast Surgeries on Subsequent Breast Reconstruction

Complications of Silicone Cosmetic Procedures Among Medical Tourists from the Bronx, New York: A Retrospective Analysis

Breast Implant-Related EBV + Diffuse Large B-Cell Lymphoma—Case Report and Review of the Literature

Reasons for Silicone Breast Implant Removal After Long-Term Implantation in Chinese Patients Without Complications: A Questionnaire-Based Study

A Comparative Assessment of Three Planes of Implant Placement in Breast Augmentation: A Bayesian Analysis

Complications of Aesthetic and Reconstructive Breast Implant Capsulectomy: An Analysis of 7486 Patients Using Nationwide Outcomes Data

Oncoplastic Reconstruction in the Setting of Prior Cosmetic Augmentation

Breast Implant Removal-Only: The Role of Targeted Compression

Mortality Rate in Breast Implant Surgery: Is an Additional Procedure Worthwhile to Mitigate BIA-ALCL Risk?

Breast Reconstruction in Patients with Prior Breast Augmentation: Searching for the Optimal Reconstructive Option

Analysis of Breast Follow-Up Results in Patients after Polyacrylamide Hydrogel (PAAG) or Silicone Prosthesis Removal.

Current State of Evidence-Based Long-Term Monitoring Protocols for Breast Plastic Surgery Patients